Diastolic heart failure in the elderly

Heart Failure Reviews

Volumn 7, Issue 1, 2002, Pages 17-27

  Kitzman, Dalane W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Diastolic function; Elderly; Heart failure

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CARDIOVASCULAR AGENT; DIGOXIN; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL; LOSARTAN; NITRATE; SPIRONOLACTONE;

AGED; AGING; BLOOD PRESSURE REGULATION; BLOOD VESSEL COMPLIANCE; CARDIOVASCULAR PARAMETERS; CHRONICITY; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DIASTOLE; DIET THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; EXERCISE; EXERCISE TOLERANCE; GERIATRIC PATIENT; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HOSPITAL PATIENT; HUMAN; HYPERTENSION; LUNG DISEASE; LUNG EDEMA; MORBIDITY; MORTALITY; NEUROENDOCRINE SYSTEM; NONHUMAN; OUTPATIENT; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; POPULATION RESEARCH; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; SIDE EFFECT; SODIUM INTAKE; STARLING LAW; SYSTOLE; SYSTOLIC BLOOD PRESSURE; VALVULAR HEART DISEASE;

AGED; AGING; DIASTOLE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; PROGNOSIS; UNITED STATES;

EID: 0036170807     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013745705318     Document Type: Review

References (109)

1. Heart failure in the 1990s: Evolution of a major public health problem in cardiovascular medicine
2. National hospital discharge survey: Annual summary, 1993
3. Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence
4. The epidemiology of heart failure: The Framingham study
5. NIA cardiovascular aging advisory panel. Research recommendations for cardiovascular aging research
6. The natural history of congestive heart failure: The Framingham study
7. Epidemiological aspects of heart failure
8. Prevalence and mortality rate of congestive heart failure in the United States
9. Heart failure and cardiomyopathy
10. Aging and the heart
11. Age-related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility, and loading conditions
12. Age-related hemodynamic, renal, and hormonal differences among patients with congestive heart failure
13. Mechanism of altered pattern of left ventricular filling with aging in subjects without cardiac disease
14. Biological basis of the sex differential in longevity
15. Left ventricular function in hospitalized geriatric patients
16. Congestive heart failure with normal systolic funciton
17. Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension
18. Intact systolic left ventricular function in clinical congestive heart failure
19. Hypertensive hypertrophic cardiomyopathy of the elderly
20. Bedside diagnosis of preserved versus impaired left ventricular systolic function in heart failure
21. Heart failure with normal systolic function: Update of prevalence, differential diagnosis, prognosis, and therapy
22. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: Failure of the Frank-Starling mechanism
23. Cross-sectional echocardiography: A window on congestive heart failure in the elderly
24. Normal left ventricular ejection fraction in older persons with congestive heart failure
25. Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective
26. Assessing the population burden from heart failure: Need for sentinel population-based surveillance systems
27. Heart failure associated with preserved systolic function: A common and costly clinical entity
28. Diastolic dysfunction in the elderly; Genesis and diagnostic and therapeutic implications
29. Defining diastolic heart failure
30. How do diagnose diastolic heart failure
31. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study
32. Doppler assessment of diastolic function comes of age
33. Heart failure with normal ejection fraction: The V-HeFT study
34. Diastolic heart failure
35. Defining diastolic dysfunction
36. Guidelines for the evaluation and management of heart failure
37. Isolated diastolic heart failure: Does it exist? Characterization of an important syndrome among the elderly
38. Importance of heart failure with preserved systolic in the elderly
39. Pulmonary edema in coronary artery disease without cardiomegaly: Paradox of the stiff heart
40. Idiopathic restrictive cardiomyopathy
41. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis
42. Survival of heart failure patients with preserved versus impaired systolic function: The prognostic implication of blood pressure
43. Hypertrophic cardiomyopathy in the elderly: A frequently misdiagnosed disease
44. Prognosis of diastolic heart failure: Framingham Heart Study
45. Prevalence and clinical correlates of diastolic heart failure: Framingham Heart Study
46. The natural history of isolated left ventricular diastolic dysfunction
47. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure
48. Course and prognosis in patients ≥ 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction
49. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction
50. Predictors of congestive heart failure in the elderly: The Cardiovascular Health Study
51. Congestive heart failure in the community
52. Incidence and aetiology of heart failure: A population-based study
53. Survival of elderly men with congestive heart failure
54. Inotropic and lusitropic abnormalities in the genesis of heart failure
55. The natural history of heart failure with preserved left ventricular systolic function
56. Flash pulmonary edema: Association with hypertension, reocurrence despite coronary revascularization
57. The utility of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function
58. Health-related quality of life in elderly patients with heart failure due to primary diastolic vs. primary systolic left ventricular dysfunction
59. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease
60. Outcome of congestive heart failure in the elderly: Influence of left ventricular systolic function. The Cardiovascular Health Study
61. Heart failure in the elderly: Systolic and diastolic dysfunction
62. Exercise intolerance in patients with heart failure: Role of diastolic dysfunction
63. Reproducibility of cardiopulmonary exercise testing in elderly heart failure patients
64. Prediction of peak oxygen uptake from cycle exercise test work level in heart failure patients > 65 years of age
65. Aerobic capacity in elderly patients with heart failure due to primary diastolic dysfunction is severely reduced and is similar to systolic dysfunction
66. The Pathogenesis of Acute Pulmonary Edema Associated with Hypertension
67. Cardiac cycle dependent changes in aortic area and aortic distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance
68. Inability of the six-minute walk test to identify functional capacity (VO2MAX) changes in elderly heart failure patients
69. Ventilatory threshold in elderly patients with congestive heart failure due to primary diastolic dysfunction
70. Plasma atrial and brain natriuretic peptides in elderly patients with heart failure due to diastolic vs systolic left ventricular function
71. Assessment of leg arterial vasodilatory capacity in elderly heart failure patients and normals using phase contrast magnetic resonance imaging
72. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise
73. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure
74. Is flash pulmonary edema due to diastolic dysfunction or transient systolic dysfunction?
75. Altered load: An important component of impaired diastolic function in hypertension and heart failure
76. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling
77. Assessment of cardiac function
78. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
79. Mortality and morbidity results from the European Working Party on high blood pressure in the elderly trial
80. Cardiovascular aging research: The next horizons
81. Diuretics vs adrenergic blockers for treatment of hypertension. Lessons from ALLHAT
82. Treatment of heart failure due to diastolic dysfunction
83. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance
84. Effects of short-term administration of verapamil on left ventricular filling dynamics measured by a combined hemodynamic-ultrasonic technique in patients with hypertrophic cardiomyopathy
85. Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy?
86. Analysis of relaxation in the evaluation of ventricular function of the heart
87. Diastolic failure: Pathophysiology and therapeutic implications
88. Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: Focus on felodipine
89. Effect of amlodipine on morbidity and mortality in severe chronic heart failure
90. Effects of felodipine on left ventricular systolic and diastolic performance in congestive heart failure
91. Vascular versus myocardial effects of calcium antagonists
92. Comparison of effects on peak oxygen consumption, quality of life, and neurohormones of felodipine and enalapril in patients with congestive heart failure
93. Differential effects of enalaprilat and felodipine on diastolic function during exercise in dogs with congestive heart failure
94. Mechanism of augmented rate of left ventricle filling during exercise
95. Effect of heart failure on the mechanism of exercise induced augmentation of mitral valve flow
96. Diastolic dysfunction in experimental heart failure
97. Enhanced load dependence of relaxation in heart failure: Clinical implications
98. Impaired chronotropic response to exercise in patients with congestive heart failure
99. Left ventricular diastolic function and calcium channel blockers in hypertrophic cardiomyopathy
100. The effect of digoxin on mortality and morbidity in patients with heart failure
101. Cardiac hypertrophy: The consequences for diastole
102. Cardiac renin-angiotensin system in cardiac hypertrophy and failure
103. Reduction in left ventricular mass in patients with systemic hypertension treated with Enalapril, Lisionopril, or Fosenopril
104. Intracardiac ACE inhibition improves diastolic distensibility in patients with left ventricular hypertrophy due to aortic stenosis
105. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction
106. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
107. Exercise training improves aerobic capacity in elderly patients with diastolic heart failure: A randomized, controlled trial